ArticleCureus2024
Recurrent Thrombosis in a Very Elderly Patient With Dementia, Atrial Fibrillation, and Idiopathic Thrombocytopenic Purpura on Eltrombopag Treatment.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder, leading to an increased bruising and bleeding tendency. Eltrombopag, a thrombopoietin receptor agonist, is an effective treatment option even in elderly patients with ITP. In this report, we present a case of recurrent thrombosis, presenting as acute myocardial infarction and cerebral infarction, in a very elderly patient with dementia, atrial fibrillation, and ITP on eltrombopag treatment. Multiple comorbidities with thrombosis and bleeding risks posed a therapeutic dilemma. Conditions unique to the elderly, such as cognitive impairment or frailty, led to a delayed diagnosis. This case gives an insight into how to manage a practical therapeutic problem in such a case. Physicians need to understand conditions unique to the elderly, such as cognitive impairment, frailty, or quality of life that influence treatment goals. These efforts can help provide health benefits while minimizing treatment risks, especially in elderly patients with multiple comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.